This preparation is a practitioner-directed formulation that integrates two specific active ingredients—Mupirocin (2%) and Betamethasone (0.1%)—into a precise 1:1 ratio.
- By incorporating these agents into a specialized anhydrous (water-free) ointment base, the pharmacist creates a stable delivery system that remains in direct contact with the localized tissue for an extended duration.
- The base is engineered to act as a protective physical barrier while facilitating the topical application of the prescribed agents to sensitive areas, as specified by the healthcare provider’s prescription.